![Quiver Logo](/static/img/logo-icon.png)
![GNTA logo](https://quiver-logos.s3.us-east-2.amazonaws.com/gnta.png)
Genenta Science S.p.A. American Depositary Shares
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view GNTA Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of GNTA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by GNTA's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to GNTA
Recent picks made for GNTA stock on CNBC
ETFs with the largest estimated holdings in GNTA
Flights by private jets registered to GNTA
![Quiver Logo](/static/img/logo-icon.png)